Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-29

Clinical Trial Update: Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial of Bexxar (tositumomab) combined with external beam radiation therapy in non-Hodgkin lymphoma; the study was terminated with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bexxar (tositumomab)

Snippet

Sponsor: Stanford University | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: TERMINATED | Results posted: 2017-03-29